SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Earnings Per Share (Basic)
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Earnings Per Share (Basic) of -$3.10 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$3.10.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.43.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.05.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$32.91.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for fiscal 2025 was -$7.16.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for fiscal 2024 was -$79.65.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for fiscal 2023 was -$3.53.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. earnings per share, basic for fiscal 2022 was -$5.04.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.10 10-Q · filed 2026-09-24 | -$6.97 10-Q · filed 2026-09-24 | ||||||
| 2026-03-31 | -$0.43 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | -$7.16 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | -$1.05 10-Q · filed 2025-11-13 | -$7.22 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$32.91 10-Q · filed 2026-09-24 | -$3.29 10-Q · filed 2025-08-13 | -$88.24 10-Q · filed 2026-09-24 | -$8.82 10-Q · filed 2025-08-13 | ||||
| 2025-03-31 | -$7.60 10-Q · filed 2026-05-15 | -$0.30 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | -$79.65 10-K · filed 2026-03-31 | -$3.19 10-K · filed 2025-02-26 | ||||||
| 2024-09-30 | -$39.83 10-Q · filed 2025-11-13 | -$1.59 10-Q · filed 2024-11-13 | -$86.30 10-Q · filed 2025-11-13 | -$3.45 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | -$24.12 10-Q · filed 2025-08-13 | -$0.96 10-Q · filed 2024-09-04 | -$44.98 10-Q · filed 2025-08-13 | -$1.80 10-Q · filed 2024-09-04 | ||||
| 2024-03-31 | -$0.83 10-Q · filed 2025-05-08 | -$0.10 10-Q · filed 2024-05-13 | ||||||
| 2023-12-31 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.73 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$2.93 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$3.53 10-K · filed 2025-02-26 | -$0.44 10-K · filed 2024-03-21 | |||
| 2023-09-30 | -$0.91 10-Q · filed 2024-11-13 | -$0.11 10-Q · filed 2023-11-13 | -$2.12 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$2.72 10-Q · filed 2024-11-13 | -$0.34 10-Q · filed 2023-11-13 | $2.04 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||
| 2023-06-30 | -$1.23 10-Q · filed 2024-09-04 | -$0.15 10-Q · filed 2023-08-14 | -$1.81 10-Q · filed 2024-09-04 | -$0.23 10-Q · filed 2023-08-14 | $1.12 derived: net income ÷ weighted average shares · filed 2024-09-04 | $3.37 derived: net income ÷ weighted average shares · filed 2024-09-04 | ||
| 2023-03-31 | -$0.57 10-Q/A · filed 2024-09-04 | -$0.07 10-Q · filed 2023-05-25 | $0.49 derived: net income ÷ weighted average shares · filed 2024-09-04 | $1.60 derived: net income ÷ weighted average shares · filed 2024-09-04 | $10.64 derived: net income ÷ weighted average shares · filed 2024-09-04 | |||
| 2022-12-31 | $0.18 derived: net income ÷ weighted average shares · filed 2024-09-04 | $0.79 derived: net income ÷ weighted average shares · filed 2024-09-04 | $4.17 derived: net income ÷ weighted average shares · filed 2024-09-04 | -$5.04 10-K/A · filed 2024-09-04 | -$0.29 10-K · filed 2023-03-15 | |||
| 2022-09-30 | -$0.10 10-Q · filed 2023-11-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.23 10-Q · filed 2023-11-13 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.06 10-Q · filed 2023-08-14 | -$0.14 10-Q · filed 2023-08-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.07 10-Q · filed 2023-05-25 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-05-25 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-05-25 | |||||
| 2021-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.12 10-K · filed 2023-03-15 | |||||
| 2021-09-30 | -$0.02 10-Q · filed 2022-11-14 | -$0.07 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |